Caldwell Trust’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
Caldwell Trust's AZN Position: Q2 2026 in Review
Caldwell Trust increased its AstraZeneca (AZN) stake by 28% in Q2 2026, buying an estimated $345K and bringing the position to 8,454 shares worth $1.6M. The position accounts for 0.13% of the portfolio, ranked #133.
Caldwell Trust first reported a position in AZN in Q4 2019 and has held it in 21 quarters since. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Caldwell Trust held 8,454 shares of AstraZeneca worth $1.6M as of Q2 2026.
- Caldwell Trust bought 1,836 AstraZeneca shares in Q2 2026, an estimated $345K.
- AstraZeneca made up 0.13% of Caldwell Trust's portfolio in Q2 2026, its #133 holding.
- Caldwell Trust first reported a position in AstraZeneca in Q4 2019 and has held it in 21 quarters since.
- 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Caldwell Trust's 13F filing for Q2 2026, filed 3 Aug 2026.